URAC Specialty Pharmacy Accreditation FAQ — Every Question Answered

Last updated: April 2026

Direct answers to every question specialty pharmacies ask about URAC accreditation — cost, timeline, PBM requirements, common deficiencies, the ACHC comparison, small pharmacy programs, and the v6.0 standards transition. No "contact us for more information." The answers are here.

What Is URAC Specialty Pharmacy Accreditation?

URAC Specialty Pharmacy Accreditation is a three-year quality credential from the Utilization Review Accreditation Commission recognizing specialty pharmacies that demonstrate compliance with rigorous standards across 9 operational modules. The current standard is Specialty Pharmacy Accreditation v6.0, announced October 2025, succeeding v5.0 which had been active since October 2022.

The accreditation covers every operational dimension of a specialty pharmacy: patient management, medication distribution, cold-chain integrity, clinical safety, consumer protection, staff qualifications, quality improvement, performance measurement, and reporting. Approximately 465 URAC-accredited specialty pharmacy organizations reported measurement year data in 2024. Roughly 1,900 total dispensing locations hold specialty pharmacy accreditation across all credentialing bodies (URAC, ACHC, and The Joint Commission) nationally.

For a complete overview of the accreditation program and what IHS delivers in each phase, see our URAC Specialty Pharmacy Accreditation service page.

What Is the Current Version of URAC Specialty Pharmacy Standards?

Specialty Pharmacy Accreditation v6.0 is the current standard, announced by URAC in October 2025. It succeeded v5.0, which was released in October 2022 and restructured the program into 4 primary operational modules (P-OPS, P-MD, P-PSC, PM) with more than 40 standards.

The v6.0 update reflects evolving industry best practices and technological advancements, with expanded cold-chain and distribution management requirements for the growing pipeline of complex biologics and cell/gene therapies, continued integration of technology and AI governance standards into pharmacy operations modules, and alignment with evolving PBM credentialing expectations. IHS has the strongest plain-language change-summary content in the specialty pharmacy accreditation market for both the v4-to-v5 and v5-to-v6 transitions.

What Are the 9 Modules in URAC Specialty Pharmacy v6.0?

URAC Specialty Pharmacy v6.0 is organized into 9 standard modules, each covering a distinct operational domain:

  1. Risk Management (RM) — regulatory compliance, internal controls, information systems, and business continuity
  2. Operations and Infrastructure (OPIN) — business management, staff management, and clinical leadership
  3. Performance Monitoring and Improvement (PMI) — quality management scope, data collection, and evaluation
  4. Consumer Protection and Empowerment (CPE) — protection of consumer information, consumer safeguards, and communication
  5. Pharmacy Operations (P-OPS) — scope of services, prescription processing and dispensing, dispensing accuracy, adherence monitoring, and product management
  6. Medication Distribution (P-MD) — distribution management, shipping logistics, and distribution accuracy monitoring
  7. Patient Service and Communication (P-PSC) — adverse event reporting, pharmacovigilance documentation, and clinical safety protocols
  8. Patient Management (PM) — clinical assessments at therapy initiation, individualized care plans, therapeutic interventions, and ongoing monitoring
  9. Reporting Performance Measures (RPT) — mandatory and exploratory performance measure tracking and submission to URAC

Each module contains multiple standards with specific compliance requirements that must be documented in your policies and procedures, demonstrated through operational evidence, and validated during the desktop review and validation review phases.

How Long Does URAC Specialty Pharmacy Accreditation Take?

URAC specialty pharmacy accreditation realistically takes 9 to 12 months from consulting engagement kickoff to final accreditation committee decision. URAC states the process takes six months or less from formal application submission, but that timeline assumes your pharmacy already has compliant policies, functioning patient management programs, and audit-ready documentation.

The six phases and their typical durations:

  • Standard-by-Standard Review: Months 1-2 — consultant evaluates current state against v6.0 standards across all 9 modules
  • Document Preparation: Months 2-5 — IHS provides policy templates for all applicable modules; your team customizes policies and procedures to your operations with IHS assistance as needed
  • Mock Desktop Review in Starfinch: Month 5 — IHS reviews all documents in Starfinch and provides feedback before application submission
  • Application Submission via AccreditNet: Months 5-6 — define scope, upload all documentation
  • Desktop Review and RFI Response: Months 6-7 (30-45 days) — URAC Lead Reviewer scores standards, up to 2 rounds of RFIs
  • Validation Review: Months 7-8 (1-3 days) — on-site, virtual, or hybrid inspection with staff interviews and file audits
  • Committee Review and Decision: Months 8-9 (10 business days) — anonymous report voted on by URAC Accreditation Committee

How Much Does URAC Specialty Pharmacy Accreditation Cost?

URAC does not publish a flat-rate fee schedule. Accreditation fees are dynamically calculated based on your total annual pharmacy revenue, closely held company status, specific business model, and number of physical dispensing sites. The official standards document costs $295. URAC's Small Business program offers special affordable pricing for eligible independent pharmacies under a revenue threshold.

Consulting fee ranges: Comprehensive Standard-by-Standard Review is scoped per engagement Targeted compliance assistance is scoped per engagement Hourly rates are not published; engagements are scoped per client.

For a detailed cost breakdown including internal resource requirements, see our URAC Specialty Pharmacy Accreditation Cost Guide.

Which PBMs Require URAC Specialty Pharmacy Accreditation?

OptumRx contractually requires URAC, ACHC, or TJC accreditation for specialty pharmacy network participation. CVS Caremark and Express Scripts maintain similar credentialing requirements for inclusion in their specialty pharmacy networks and limited distribution networks (LDNs). These three PBMs collectively control 66% of all pharmacy-dispensed specialty drug revenues.

Beyond PBMs, drug manufacturers increasingly require accreditation before granting exclusive dispensing contracts for high-cost specialty and orphan drugs. If your pharmacy cannot demonstrate current URAC (or equivalent) accreditation, you are excluded from limited distribution networks and the revenue they represent.

Approximately 66% of commercial payers prefer URAC accreditation specifically, making it the dominant standard in the specialty pharmacy market.

Does My Specialty Pharmacy Need URAC Accreditation?

If your pharmacy dispenses specialty medications and wants to participate in PBM specialty networks or access limited distribution drugs, then yes — accreditation is effectively mandatory. The specialty pharmaceutical market is not optional: US specialty dispensing revenue reached $265 billion in 2024 with 8% annual growth, and 75% of the roughly 7,000 drugs currently in clinical development are classified as specialty medications.

Specific triggers that make accreditation necessary:

  • You want to join or remain in OptumRx, CVS Caremark, or Express Scripts specialty pharmacy networks
  • You are pursuing limited distribution drug contracts from manufacturers
  • You are a hospital outpatient pharmacy seeking to leverage 340B pricing on specialty medications
  • PBM vertical integration is threatening your independent pharmacy's competitive position
  • You operate in North Carolina and want statutory protection against PBM credentialing overreach

What Is the Difference Between URAC and ACHC Specialty Pharmacy Accreditation?

URAC and ACHC are the two most widely recognized specialty pharmacy accreditors, alongside The Joint Commission. URAC is preferred by approximately 66% of commercial payers and emphasizes clinical patient management, operational quality metrics, and performance measurement reporting. ACHC focuses on pharmacy operations and has strategic partnerships with compliance firms serving independent pharmacies, including R.J. Hedges & Associates.

Key differences: URAC has 9 standard modules with deep clinical patient management requirements; ACHC structures its standards around operational pharmacy practice. URAC requires performance measure reporting to an aggregate database; ACHC has different reporting requirements. Dual accreditation is becoming standard industry practice as manufacturers increasingly require multiple validations for limited distribution drug access.

For a detailed side-by-side analysis, see our URAC vs ACHC Specialty Pharmacy Accreditation comparison.

Should My Pharmacy Get URAC, ACHC, or Both?

Start with URAC if your primary goal is commercial payer network access and PBM inclusion — 66% of commercial payers prefer it. Add ACHC if manufacturers of limited distribution drugs you want to dispense specifically mandate ACHC accreditation, or if you operate in segments where ACHC has stronger recognition (such as DMEPOS-adjacent services).

Dual accreditation is increasingly the answer for pharmacies that want maximum flexibility. IHS advises on sequencing (which to pursue first), cost optimization (reusing documentation across both applications), and timeline management (overlapping preparation periods to reduce total elapsed time).

What Are the Most Common URAC Specialty Pharmacy Survey Deficiencies?

The most frequently flagged deficiencies, by module:

  • OPIN Module — Primary Source Verifications: Missing time-stamped documentation of licensure and credential verifications, or verifications not conducted at the required frequency
  • PM Module — Clinical Assessments: Failure to consistently document required patient management clinical assessments within pharmacy management software at initiation of therapy. This is the single most flagged deficiency category.
  • P-MD Module — Temperature/Cold-Chain: Inadequate temperature qualification testing and cold-chain integrity documentation, especially for 36-hour shipping windows
  • CPE Module — Grievance Packets: Missing mandatory state regulatory agency contact information in patient grievance and complaint materials
  • PM Module — Non-Individualized Care Plans: Using identical boilerplate care plans across patients instead of tailoring to individual comorbidities and medication regimens
  • OPIN Module — Staff Competency Assessments: Incomplete, inconsistent, or poorly documented competency assessments over time
  • RPT Module — Performance Measures: Failures in tracking and submitting mandatory measures on schedule
  • PMI Module — Quality Committee Minutes: Minutes lacking actionable root cause analysis or follow-up documentation

IHS builds prevention protocols for each of these deficiencies into every standard engagement.

What Is AccreditNet and How Does My Pharmacy Use It?

AccreditNet is URAC's online accreditation management platform. It is where your pharmacy submits the formal application (defining scope of services, organizational structure, and delegation activities), uploads all compliance documentation for desktop review, receives and responds to Requests for Information (RFIs), and tracks your accreditation status throughout the process.

During the desktop review phase, a URAC Lead Reviewer scores each standard as Met or Not Met within AccreditNet and issues RFIs through the platform for any gaps. IHS manages the entire AccreditNet submission process, structuring your documentation in the format URAC reviewers expect to minimize avoidable RFIs.

What Happens During a URAC Validation Review for Specialty Pharmacy?

The URAC Validation Review is a 1-to-3-day inspection — conducted on-site, virtually, or as a hybrid — where URAC reviewers verify that your actual pharmacy operations match your documented policies. No comprehensive preparation guide for this review exists from any external source. Here is what it involves:

  • Staff interviews: Reviewers test clinical and operational staff knowledge of your policies, procedures, and their specific responsibilities under each applicable standard
  • Facility tours: Physical inspection of dispensing areas, storage facilities, cold-chain infrastructure, clean rooms (if applicable), and patient consultation spaces
  • Patient file audits: Random selection of patient records to verify individualized care plans, clinical assessments at therapy initiation, therapeutic intervention documentation, and adverse event reporting
  • Distribution log reviews: Verification of temperature qualification testing records, shipping logs, and cold-chain audit documentation

IHS prepares your team with mock interview sessions, facility walkthrough rehearsals, and patient file pre-audits. Every staff member who may interact with a reviewer must demonstrate competence — not just awareness — of the standards they are responsible for.

Is There a URAC Specialty Pharmacy Accreditation Program for Small Pharmacies?

Yes. URAC offers a dedicated Small Business Specialty Pharmacy Accreditation program with special affordable pricing for eligible independent, community, and private pharmacies that fall under a revenue threshold. Qualifying small businesses can self-report certain metrics rather than undergoing the full measurement and reporting process required of larger organizations.

This program exists because URAC recognizes that independent pharmacies face existential competitive pressure from PBM vertical integration. Without an accessible pathway to accreditation, these pharmacies cannot compete for specialty network inclusion. Contact IHS to determine whether your pharmacy qualifies for the small business program and to develop a right-sized engagement plan.

What Changed From URAC Specialty Pharmacy v5.0 to v6.0?

URAC announced v6.0 updates to Specialty Pharmacy, Mail Service Pharmacy, and Pharmacy Benefit Management programs in October 2025. The key changes reflect evolving industry practices and include expanded cold-chain and distribution management requirements for complex biologics and cell/gene therapies, continued integration of technology and AI governance standards into pharmacy operations modules, and updates to align with the evolving PBM credentialing landscape.

For context, v5.0 (October 2022) had previously restructured the program significantly — consolidating standards into 4 primary operational modules (P-OPS, P-MD, P-PSC, PM) with more than 40 standards, simplifying the application process, and introducing new patient management and distribution management standards. IHS has the strongest plain-language change-summary content in the market for both transitions.

Can a Pharmacy Lose URAC Accreditation Mid-Cycle?

Yes. The 3-year accreditation is not a set-it-and-forget-it credential. URAC conducts random virtual monitoring reviews throughout the accreditation cycle and requires annual quality reporting with mandatory and exploratory performance measures. If monitoring reveals significant operational non-compliance, failure to submit required reports, or material unreported changes to your operations, URAC can place your accreditation on Conditional or Provisional status, or revoke it entirely.

Post-accreditation compliance is an ongoing operational commitment. IHS offers monthly retainer engagements (per-engagement pricing) to help pharmacies maintain compliance between survey cycles.

What Are the URAC Patient Management (PM) Module Compliance Requirements?

The PM module is the most commonly flagged deficiency category in specialty pharmacy surveys. It requires pharmacies to conduct comprehensive clinical assessments within pharmacy management software at initiation of therapy, develop individualized care plans tailored to each patient's specific comorbidities, disease state, and medication regimen, document all therapeutic interventions and clinical outcomes, assess psychosocial barriers and financial constraints as part of the patient evaluation, and maintain ongoing patient monitoring records.

The critical failure point: boilerplate care plans. URAC reviewers compare patient files during validation reviews, and identical care plans across multiple patients are immediately flagged as non-compliant. IHS provides PM compliance policy templates and clinical documentation frameworks designed to integrate with your existing pharmacy operations — not as a separate administrative burden layered on top of clinical work.

Does North Carolina Law Protect URAC-Accredited Pharmacies From PBM Credentialing?

Yes. North Carolina Session Law 2025-69 (SB 203) provides explicit statutory protection for URAC-accredited pharmacies against PBM-imposed redundant credentialing documentation requirements that exceed North Carolina Board of Pharmacy standards. This makes URAC accreditation a legal shield for independent specialty pharmacies operating in North Carolina, preventing PBMs from imposing arbitrary credentialing hurdles beyond what the accreditation already validates.

This legislation reflects growing FTC and state legislative scrutiny of PBM anti-competitive practices and increasing pressure toward neutral third-party quality validation. IHS anticipates similar legislative activity in other states as the independent pharmacy advocacy movement gains momentum.

What Is the Difference Between URAC Specialty Pharmacy and URAC Mail Service Pharmacy Accreditation?

URAC Specialty Pharmacy Accreditation covers pharmacies dispensing specialty medications — typically high-cost, complex drugs requiring patient management, clinical monitoring, and cold-chain distribution. URAC Mail Service Pharmacy Accreditation covers mail-order dispensing operations that ship maintenance and non-specialty medications. Some pharmacies hold both designations if their operations span both categories.

URAC updated both programs simultaneously in the v6.0 release (October 2025). If your pharmacy handles both specialty and mail-order dispensing, IHS advises on which accreditation(s) apply to your specific operational scope and how to sequence applications if pursuing both.

How Much Does It Cost to Maintain URAC Accreditation Between 3-Year Cycles?

Ongoing costs between surveys include annual quality reporting infrastructure (staff time for performance measure tracking and submission), random monitoring review preparation, Quality Management Committee meeting administration, and maintaining documentation systems in audit-ready condition. URAC does not charge an annual maintenance fee separate from the accreditation cycle fee, but the internal resource commitment is real.

Many pharmacies engage consultants on a retainer basis (per-engagement pricing) to maintain compliance readiness. This is significantly less expensive than rebuilding compliance from scratch when the 3-year reaccreditation survey approaches. IHS offers ongoing compliance support retainers tailored to pharmacy size and complexity.

Ready to Get Started?

Schedule a no-obligation Standard-by-Standard Review with IHS. We will assess your current compliance posture against URAC Specialty Pharmacy v6.0 standards and give you a clear roadmap to accreditation.

Schedule a Free Discovery Session